The purpose of this paper is to investigate the clinical diagnostic value of the C13 urea breath test in the detection of Helicobacter pylori infection. The methodology of this study was to select 100 patients with epigastric discomfort who visited our hospital from January 2022 to July 2023. All patients underwent rapid urease test (RUT) and C13-urea breath test. Histological examination was used as the diagnostic gold standard to compare the diagnostic accuracy of the two methods for various diseases in patients, including the diagnostic positive rate. The diagnostic performance of the two methods (sensitivity, specificity, accuracy, negative predictive value, positive predictive value) was assessed. Results Of the 100 patients with epigastric discomfort is that 90 were diagnosed by pathologic examination. The C13-urea breath test had a higher diagnostic positive rate for duodenitis and peptic ulcers compared to RUT (P<0.05). There was no significant difference in the diagnostic positive rate between the two methods for gastric polyps, chronic gastritis, and gastric cancer (P>0.05). The C13-urea breath test had higher sensitivity, specificity, accuracy, positive predictive value, and negative predictive value compared to RUT. The specificity and accuracy of the two methods were significantly different (P<0.05), while the sensitivity, negative predictive value, and positive predictive value were not significantly different (P>0.05). This paper concludes that both the C13-urea breath test and the RUT are effective diagnostic methods for detecting H. pylori infection, but the C13-urea breath test has a higher diagnostic positivity rate and overall diagnostic performance. It provides a strong basis for clinical diagnosis and treatment, and has high clinical value. Therefore, it is worth promoting.

Xinhua Xie. Analysis of Clinical Application of C13-urea Breath Test for Detection of Helicobacter Pylori Infection. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 9: 116-121. https://doi.org/10.25236/IJFM.2023.050919.

[1] Hooton C, Keohane J, Clair J, et al. Comparison of three stool antigen assays with the 13C–urea breath test for the primary diagnosis of Helicobacter pylori infection and monitoring treatment outcome[J]. European journal of gastroenterology & hepatology, 2006, 18(6): 595-599.

[2] Lim S G, Park R W, Shin S J, et al. The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use[J]. Digestive and Liver Disease, 2016, 48(4): 385-390.

[3] McNamara D, Whelan H, Hamilton H, et al. HpSA: assessment of a new non-invasive diagnostic assay for Helicobacter pylori infection in an Irish population[J]. Irish journal of medical science, 1999, 168: 111-113.

[4] Kondratiuk N, Paliy I, Zaika S. Analysis of the prevalence of Helicobacter pylori infection and the effectiveness of eradication schemes in patients with the upper gastrointestinal tract disorders (according to the results of 13C-urea breath tests for 2006–2019)[J]. Gastroenterology Review/Przegląd Gastroenterologiczny, 2021, 16(3): 229-234.

[5] Al-Fadda M, Powe J, Rezeig M, et al. Comparison of carbon-14-urea breath test and rapid urease test with gastric biopsy for identification of Helicobacter pylori[J]. Annals of Saudi medicine, 2000, 20(2): 170-172.

[6] Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer[J]. New England journal of medicine, 2001, 345(11): 784-789.

[7] Graham D Y, Adam E, Reddy G T, et al. Seroepidemiology of Helicobacter pylori infection in India: comparison of developing and developed countries[J]. Digestive diseases and sciences, 1991, 36: 1084-1088.

[8] Lee Y C, Dore M P, Graham D Y. Diagnosis and treatment of Helicobacter pylori infection[J]. Annual review of medicine, 2022, 73: 183-195.

[9] Rokkas T, Gisbert J P, Malfertheiner P, et al. Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: a network meta-analysis[J]. Gastroenterology, 2021, 161(2): 495-507. e4.

[10] Miller A K, Williams S M. Helicobacter pylori infection causes both protective and deleterious effects in human health and disease[J]. Genes & Immunity, 2021, 22(4): 218-226.

[11] Wang X M, Yee K C, Hazeki-Taylor N, et al. Oral Helicobacter pylori, its relationship to successful eradication of gastric H. pylori and saliva culture confirmation[J]. Journal of Physiology and Pharmacology, 2014, 65(4): 559-566.

[12] Pearce C B, Duncan H D, Timmis L, et al. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease[J]. European journal of gastroenterology & hepatology, 2000, 12(4): 439-443.

[13] Bayraktar M, DABAK R. Screening of Helicobacter pylori in patients with dyspeptic complaints with the urea breath test and its usability in family medicine[J]. Turkish Journal of Family Medicine and Primary Care, 2021, 15(4): 763-768.

[14] Charpignon C, Lesgourgues B, Pariente A, et al. Peptic ulcer disease: one in five is related to neither H elicobacter pylori nor aspirin/NSAID intake[J]. Alimentary pharmacology & therapeutics, 2013, 38(8): 946-954.

[15] Apostolopoulos P, Koumoutsos I, Ekmektzoglou K, et al. Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study[J]. Scandinavian Journal of Gastroenterology, 2016, 51(2): 145-151.

[16] Gisbert J P, Aguado B, Luna M, et al. Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases[J]. Revista Espanola de Enfermedades Digestivas, 2006, 98(9): 655-665.

[17] Harrison J R, Bevan J, Furth E E, et al. AccuStat whole blood fingerstick test for Helicobacter pylori infection: a reliable screening method[J]. Journal of clinical gastroenterology, 1998, 27(1): 50-53.

[18] Su D J, Chang M H, Yang J C, et al. Fourteen-day sequential therapy is superior to 7-day triple therapy as first-line regimen for Helicobacter pylori infected children[J]. Journal of the Formosan Medical Association, 2022, 121(1): 202-209.

[19] Griñó, S. Pascual, J. Such, JA Casellas, M. Niveiro, M. Andreu, J. Sáez, E. Griñó, JM Palazón, F. Carnicer, M. Pérez-Mateo P. Comparison of diagnostic methods for Helicobacter pylori infection in patients with upper gastrointestinal bleeding[J]. Scandinavian journal of gastroenterology, 2001, 36(12): 1254-1258.

[20] Hawkey C, Avery A, Coupland C A C, et al. Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial[J]. The Lancet, 2022, 400(10363): 1597-1606.

[21] Shmuely H, Yahav J, Samra Z, et al. Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor[J]. Molecular nutrition & food research, 2007, 51(6): 746-751.